Skip to main content

Advertisement

Log in

Nodal Counts on MDCT as a Surrogate Marker for Surgical Curability in Gastric Cancer

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Thin-slice multidetector row computed tomography (MDCT) has emerged as a promising diagnostic modality in various cancers. This study was designed to evaluate the utility of metastatic nodal counts on MDCT as a surrogate maker for surgical curability in gastric cancer.

Methods

Between 2005 and 2007, a total of 92 patients with gastric cancer underwent preoperative MDCT at a slice thickness of 1.0 mm at our hospital. All regional lymph nodes showing metastatic involvement were preoperatively counted.

Results

Although the total counts of metastatic lymph nodes on MDCT were significantly smaller than those found by histopathology (P = 0.00001), there was a significant correlation between nodal counts on MDCT and histopathology by Spearman’s analysis [P < 0.0001, pathologic counts = 1.63x (counts on MDCT) + 2.5]. Nodal counts on MDCT of ≥4 were analyzed as putative pathologic nodal counts of ≥8 by the equation, and pathologic metastatic nodal counts of ≥8 were most significantly correlated with noncurative resection (P < 0.0001). According to the logistic regression analysis, nodal counts on MDCT of ≥4 were a significant independent variable for noncurative resection (P = 0.0052, odds ratio 26.68). Nodal counts on MDCT of ≥4 could distinguish noncurative patients from curative patients with 94.4% sensitivity and 71.6% specificity.

Conclusions

Nodal counts on MDCT could be a reliable surrogate maker for surgical curability of gastric cancer. This marker might enable us to select prospective candidates for additional or alternative treatments in gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Aida K, Yoshikawa H, Mochizuki C, et al. Clinicopathological features of gastric cancer detected by endoscopy as part of annual health checkup. J Gastroenterol Hepatol. 2008;23:632–7.

    Article  PubMed  Google Scholar 

  2. Otsuji E, Yamaguchi T, Sawai K, Okamoto K, Takahashi T. Total gastrectomy with simultaneous pancreaticosplenectomy or splenectomy in patients with advanced gastric carcinoma. Br J Cancer. 1999;79:1789–93.

    Article  PubMed  CAS  Google Scholar 

  3. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49.

    Article  PubMed  Google Scholar 

  4. Pan Z, Zhang H, Yan C, et al. Determining gastric cancer resectability by dynamic MDCT. Eur Radiol. 2010;20:613–20.

    Article  PubMed  Google Scholar 

  5. Shinohara T, Ohyama S, Yamaguchi T, et al. Clinical value of multidetector row computed tomography in detecting lymph node metastasis of early gastric cancer. Eur J Surg Oncol. 2005;31:743–8.

    Article  PubMed  CAS  Google Scholar 

  6. Chen CY, Hsu JS, Wu DC, et al. Gastric cancer: preoperative local staging with 3D multi-detector row CT—correlation with surgical and histopathologic result. Radiology. 2007;242:472–82.

    Article  PubMed  Google Scholar 

  7. Yan C, Zhu ZG, Yan M, et al. Value of multidetector-row computed tomography in the preoperative T and N staging of gastric carcinoma: a large-scale Chinese study. J Surg Oncol. 2009;100:205–14.

    Article  PubMed  Google Scholar 

  8. Yanagita S, Natsugoe S, Uenosono Y, et al. Morphological distribution of metastatic foci in sentinel lymph nodes with gastric cancer. Ann Surg Oncol. 2008;15:770–6.

    Article  PubMed  Google Scholar 

  9. Kim JJ, Song KY, Hur H, Hur JI, Park SM, Park CH. Lymph node micrometastasis in node-negative early gastric cancer. Eur J Surg Oncol. 2009;35:409–14.

    Article  PubMed  CAS  Google Scholar 

  10. Kawaguchi T, Ichikawa D, Komatsu S, et al. Clinical evaluation of JCGC and TNM staging on multidetector-row computed tomography in preoperative nodal staging of gastric cancer. Hepatogastroenterology. 2011;58:838–41.

    PubMed  Google Scholar 

  11. Katai H, Yoshimura K, Maruyama K, Sasako M, Sano T. Evaluation of the new International Union Against Cancer TNM staging for gastric carcinoma. Cancer. 2000;88:1796–800.

    Article  PubMed  CAS  Google Scholar 

  12. Yoo CH, Noh SH, Kim YI, Min JS. Comparison of prognostic significance of nodal staging between old (4th edition) and new (5th edition) UICC TNM classification for gastric carcinoma. World J Surg. 1999;23:492–8.

    Article  PubMed  CAS  Google Scholar 

  13. Ichikawa D, Kurioka H, Ueshima Y, et al. Prognostic value of lymph node staging in gastric cancer. Hepatogastroenterology. 2003;50:301–4.

    PubMed  Google Scholar 

  14. Deng J, Liang H, Sun D, Wang D, Pan Y. Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China. Ann Surg Oncol. 2010;17:1259–66.

    Article  PubMed  Google Scholar 

  15. Sobin LH, Gospodarowicz MK, Wittekind C; International Union Against Cancer. TNM classification of malignant tumours. 7th ed. New York: Wiley-Blackwell; 2009. p. 73–7.

    Google Scholar 

  16. Fukuya T, Honda H, Hayashi T, et al. Lymph-node metastases: efficacy of detection with helical CT in patients with gastric cancer. Radiology. 1995;197:705–11.

    PubMed  CAS  Google Scholar 

  17. Kwee RM, Kwee TC. Imaging in assessing lymph node status in gastric cancer. Gastric Cancer. 2009;12:6–12.

    Article  PubMed  CAS  Google Scholar 

  18. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 14th ed. March 2010.

  19. Yoshikawa T, Sasako M, Yamamoto S, et al. Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer. Br J Surg. 2009;96:1015–22.

    Article  PubMed  CAS  Google Scholar 

  20. Newman E, Marcus SG, Potmesil M, et al. Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer. J Gastrointest Surg. 2002;6:212–23.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daisuke Ichikawa MD.

Additional information

Kawaguchi and Komatsu have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kawaguchi, T., Komatsu, S., Ichikawa, D. et al. Nodal Counts on MDCT as a Surrogate Marker for Surgical Curability in Gastric Cancer. Ann Surg Oncol 19, 2465–2470 (2012). https://doi.org/10.1245/s10434-012-2283-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-012-2283-9

Keywords

Navigation